ArticleAnnals of hematology2025

Improved survival in older patients with myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantation with low-dose anti-thymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis.

Yannan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.